Roche has introduced the cobas Respiratory flex test, a new diagnostic that utilises the company's temperature-activated generation of signal (TAGS) technology. This is said to be the first ...

The Roche cobas HPV test, developed by Roche Molecular Group in Switzerland, is not intended to be a first-line screening test for HPV. FDA approves Claris’ anti-infective injectable ...

Roche received a CE mark for the expanded use of its HIV monitoring test. This allows the Cobas® TaqMan® HIV-1 Test to be used in smaller laboratory settings.

Currently Roche’s cobas DNA test is only approved as a follow-up to an abnormal Pap smear for women ages 21 and over and as a co-test with a Pap smear to screen for the p16 and p18 HPV strains ...

The cobas 5800 will bring a shared clinical menu of molecular diagnostics testing capabilities to smaller and mid-size labs, and flexibility to larger labs that may use cobas 6800/8800 or systems ...

Roche’s Cobas Test for Chlamydia and Gonorrhea Granted 510 (k) Clearance in U.S. February 1, 2012 Multiplex PCR Assay for cobas 4800 system uses self-collected male urine and vaginal swab samples.